News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bioxel Pharma (BIP.V) Obtains $1 M in Financing


5/15/2008 11:10:19 AM

SAINTE-FOY, QUEBEC--(Marketwire - May 15, 2008) - Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced it has obtained an Investissement Quebec guarantee for a specific credit facility of $1 million granted by its financial institution. This credit is to be allocated to the financing of the Corporation's export contracts subject to firm orders from its customers.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES